NYQUIL COLD & FLU OTC
Generic Name and Formulations:
Acetaminophen 325mg, doxylamine succinate 6.25mg, dextromethorphan HBr 15mg; per liquiCap.
Procter & Gamble Pharmaceuticals
Indications for NYQUIL COLD & FLU:
Cough, sore throat, rhinorrhea, fever, headache, minor aches and pains.
2 caps every 6hrs; max 4 doses/24hrs.
During or within 14 days of MAOIs. Concomitant other acetaminophen products.
Hepatic dysfunction. Glaucoma. GI or GU obstruction. Asthma. Lower respiratory disoders. Pregnancy. Nursing mothers.
Analgesic + antihistamine + antitussive.
See Contraindications. Hypertensive crisis with MAOIs. Increased risk of hepatotoxicity with ≥3 alcoholic drinks/day; avoid. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, excitability in children, hepatotoxicity (overdosage).
LiquiCaps—12, 20, 40, 60; Liq—6oz, 10oz
Clinical Pain Advisor Articles
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Methadone Improves Short-Term Outcomes Better Than Morphine in Neonatal Abstinence Syndrome
- Addressing Rare Headache Disorders: Acute Confusional Migraine
- Hospital-Owned Practices Associated With Positive Workplace Perceptions Among Staff
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Chinese Traditional Medicine Showed Effectiveness on Pain, Quality of Life in Advanced Cancer